Chemotherapy Use and Survival Among Young and Middle-Aged Patients With Gastric Cancer
Open accessThe DOI matches its Crossref record; 53 of the 53 references it cites were found in a registry or an index.
Abstract
INTRODUCTION: Treatments for young patients with gastric cancer (GC) remain poorly defined, and their effects on survival are uncertain. We aimed to investigate the receipt of chemotherapy by age category (18-49, 50-64, and 65-85 years) and explore whether age differences in chemotherapy matched survival gains in patients with GC. METHODS: Patients who were histologically diagnosed with GC were included from a Chinese multi-institutional database and the Surveillance, Epidemiology, and End Results database. There were 5,122 and 31,363 patients aged 18-85 years treated between 2000 and 2014, respectively. Overall survival and stage-specific likelihood of receiving chemotherapy were evaluated. RESULTS: Of the 5,122 and 31,363 patients in China and Surveillance, Epidemiology, and End Result data sets, 3,489 (68.1%) and 18,115 (57.8%) were men, respectively. Younger (18-49 years) and middle-aged (50-64 years) patients were more likely to receive chemotherapy compared with older patients (65-85 years) (64.9%, 56.7%, and 45.4% in the 3 groups from the China data set). Among patients treated with surgery alone, a significantly better prognosis was found in younger and middle-aged patients than their older counterparts; however, no significant differences were found in overall survival among age subgroups in patients who received both surgery and chemotherapy, especially in the China data set. The survival benefit from chemotherapy was superior among older patients (all P < 0.0001) compared with that among younger and middle-aged patients in stage II and III disease. DISCUSSION: Potential overuse of chemotherapy was found in younger and middle-aged patients with GC, but the addition of chemotherapy did not bring about matched survival improvement, especially in the China data set.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Figures


Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
The source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“However, no differences in outcome across age groups emerged in gastric cancer patients receiving surgery plus adjuvant chemotherapy, potentially reflecting an abuse of relatively inactive chemotherapy in young and physically fitter patients.267”
From Meta-hallmarks of aging and cancer (2023) · cites this paper as [267]
Experimental — accuracy not yet measuredIn the citing paper
“Along similar lines, significantly improved disease outcome has been linked to an age % 64 in patients with gastric cancer receiving surgery.267”
From Meta-hallmarks of aging and cancer (2023) · cites this paper as [267]
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Bray, F., Ferlay, J., Soerjomataram, I., Siegel, R. L., Torre, L. A., & Jemal, A. (2018) · CA: A Cancer Journal for Clinicians · doi:10.3322/caac.21492 · Cited by 84,109
Japanese gastric cancer treatment guidelines 2014 (ver. 4)
Japanese Gastric Cancer Association (2017) · Gastric Cancer · doi:10.1007/s10120-016-0622-4 · Cited by 2,429
Japanese Gastric Cancer Association
(2007) · Encyclopedia of Cancer and Society · doi:10.4135/9781412953979.n332 · Cited by 1,261
Noh, S. H., Park, S. R., Yang, H.-K., Chung, H. C., Chung, I.-J., Kim, S.-W., Kim, H.-H., Choi, J.-H., Kim, H.-K., Yu, W., et al. (2014) · The Lancet Oncology · doi:10.1016/s1470-2045(14)70473-5 · Cited by 1,049
7th Edition of the AJCC Cancer Staging Manual: Stomach
Washington, K. (2010) · Annals of Surgical Oncology · doi:10.1245/s10434-010-1362-z · Cited by 979 · cited 1×
“Tumor–node–metastasis staging of all patients was restaged according to the 7th edition of the American Joint Committee on Cancer (AJCC) Staging Manual of the AJCC/ International Union Against Cancer (25).”
Gastric cancer: Asia and the world
Sano, T. (2017) · Gastric Cancer · doi:10.1007/s10120-017-0694-9 · Cited by 807
Benefit of Adjuvant Chemotherapy for Resectable Gastric Cancer: A Meta-analysis
(2010) · JAMA · doi:10.1001/jama.2010.534 · Cited by 794
Yu, J., Huang, C., Sun, Y., Su, X., Cao, H., Hu, J., Wang, K., Suo, J., Tao, K., He, X., et al. (2019) · JAMA · doi:10.1001/jama.2019.5359 · Cited by 690
Self-citationHu, Y., Huang, C., Sun, Y., Su, X., Cao, H., Hu, J., Xue, Y., Suo, J., Tao, K., He, X., et al. (2016) · Journal of Clinical Oncology · doi:10.1200/jco.2015.63.7215 · Cited by 686
Self-citationManagement of gastric cancer in Asia: resource-stratified guidelines
Shen, L., Shan, Y.-S., Hu, H.-M., Price, T. J., Sirohi, B., Yeh, K.-H., Yang, Y.-H., Sano, T., Yang, H.-K., Zhang, X., et al. (2013) · The Lancet Oncology · doi:10.1016/s1470-2045(13)70436-4 · Cited by 461 · cited 2×
“These practicesmay indicate overtreatment, especially in Chinese patients, because previous and current guidelines do not definitely recommend chemotherapy in stage I patients and still indicate some disputes of chemotherapy in some stage II patients (16,33,38).”
Cited by
Meta-hallmarks of aging and cancer
López-Otín, C., Pietrocola, F., Roiz-Valle, D., Galluzzi, L., & Kroemer, G. (2023) · Cell Metabolism · doi:10.1016/j.cmet.2022.11.001 · Cited by 529
Zhang, T., Chen, H., Zhang, Y., Yin, X., Man, J., Yang, X., & Lü, M. (2021) · Journal of Cancer · doi:10.7150/jca.62734 · Cited by 40
“GC is frequently diagnosed at 50-70 years old [10, 24, 25], which might result in a heavy GC burden in the elderly population.”
BackgroundSelf-citationZhang, C., Tang, R., Zhu, H., Ge, X., Wang, Y., Wang, X. L., & Miao, L. (2022) · Scientific Reports · doi:10.1038/s41598-022-10156-5 · Cited by 25
Emerging trends in early-onset gastric cancer
Wang, X., Gao, X., Yu, J. M., Zhang, X., & Nie, Y. (2024) · Chinese Medical Journal · doi:10.1097/cm9.0000000000003259 · Cited by 29
“[12,13] The incidence of EOGC has been consistently rising over the past half-century.”
BackgroundInfluentialSelf-citationVariation in Treatment Patterns of Patients with Early-Onset Gastric Cancer
LaPelusa, M. B., Shen, C., Gillaspie, E. A., Cann, C., Lambright, E. S., Chakravarthy, A. B., Gibson, M. K., & Eng, C. (2022) · Cancers · doi:10.3390/cancers14153633 · Cited by 20
Metadata
- Authors
- Jiang, Y., Xie, J., Huang, W., Chen, H., Xi, S., Li, T., Chen, C., Sun, Z., Hu, Y., Liu, W., Yu, J., Zhou, Z., Cai, S., & Li, G.
- Affiliations
- Sun Yat-sen University (CN)
- Nanfang Hospital (CN)
- Sun Yat-sen University Cancer Center (CN)
- Corresponding author
- Li, Tuanjie
- Zhou, Zhiwei
- Cai, Shirong
- Li, Guoxin
- ORCID
- Venue
- Clinical and Translational Gastroenterology
- Published
- 2020-10
- Volume
- 11
- Issue
- 10
- Pages
- e00253
- ISSN
- 2155-384X (ISSN-L)
- PMC
- PMC7556366
- OpenAlex
- W3094499069
- Cited by
- 18
- References
- 53
- Citations by year
- 2026: 1 · 2025: 6 · 2024: 4 · 2023: 4 · 2022: 2 · 2021: 1
- FWCI
- 0.99
- Type
- journal article
- Language
- en
- Open access
- gold
- doi.org
- Licence
- Locations
- Clinical and Translational Gastroenterology (publishedVersion, cc-by-nc-nd)
- Europe PMC (PubMed Central) (publishedVersion, other-oa)
- PubMed Central (publishedVersion, cc-by-nc-nd)
- PubMed (publishedVersion)
- Funders
- National Natural Science Foundation of China (81600510, 81872013, 81672446)
- Natural Science Foundation of Guangdong Province
- Southern Medical University
- Nanfang Hospital
- National Key Research and Development Program of China (2017YFC0108300)
- Topics
- Health Sciences › Medicine › Oncology › Gastric Cancer Management and Outcomes
- Health Sciences › Medicine › Surgery › Intraperitoneal and Appendiceal Malignancies
- Health Sciences › Medicine › Surgery › Esophageal Cancer Research and Treatment
- Keywords
- gastric cancer, chemotherapy use, age differences, overall survival, young and middle-aged patients, surgical treatment, stage-specific survival, SEER database, China
- MeSH terms
- Adolescent, Adult, Age Factors, Aged, Aged, 80 and over, Antineoplastic Agents, China, Female, Gastrectomy, Humans, Male, Middle Aged, Neoplasm Staging, Prognosis, Stomach Neoplasms, United States, Treatment Outcome, Chemotherapy, Adjuvant, SEER Program, Kaplan-Meier Estimate, Young Adult, Datasets as Topic
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
How to cite
Cite CoChat for the checks on this page, and the paper for its own findings.
- This page
- CoChat. (2026). Citation check: Chemotherapy Use and Survival Among Young and Middle-Aged Patients With Gastric Cancer. https://app.cochat.ai/papers/10.14309/ctg.0000000000000253
- The paper
- Jiang, Y., Xie, J., Huang, W., Chen, H., Xi, S., Li, T., Chen, C., Sun, Z., Hu, Y., Liu, W., Yu, J., Zhou, Z., Cai, S., & Li, G. (2020). Chemotherapy Use and Survival Among Young and Middle-Aged Patients With Gastric Cancer. Clinical and Translational Gastroenterology. https://doi.org/10.14309/ctg.0000000000000253
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.